So this topped the leaderboard for comments- which understandably brought it to my attention.
Now I'm an ex-holder, but have a lot of respect for the company and if you dig back through ancient history you'll find I was a big fan of 2591. So this post is not meant as a troll in any way.
Now I understand the argument that if a stock is notably undervalued, and the company has the cash, buy backs are good.
But I would have though that, given that NEU is looking to take 2591 to Ph III for several indications, that an extra $50m in the bank could be quite useful. I have to admit to having been slightly confounded by the decision when I saw it. I'd note that, given the market cap is way over $1b, pulling $50m worth of shares off the register isn't that much of a dent.
I realise the company has ~$200m cash in the bank- well done them- but my gut reaction would have been to hold back until they'd gotten 2591 licenced. My understanding is that the company is still somewhat inderdependent with Acadia so I would have held back until the company either had independent income or at least had diversified its co-dependencies.
If I'm missing something, happy to learn what that is.
- Forums
- ASX - By Stock
- Why NEU shareholders should love the buyback !!!
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.00%
!
$12.54

So this topped the leaderboard for comments- which...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.54 |
Change
0.000(0.00%) |
Mkt cap ! $1.559B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 584 | $13.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.78 | 12 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 584 | 13.490 |
1 | 128 | 13.380 |
1 | 5 | 13.300 |
1 | 2833 | 13.130 |
2 | 2 | 13.030 |
Price($) | Vol. | No. |
---|---|---|
11.780 | 12 | 1 |
12.500 | 998 | 1 |
12.630 | 2187 | 2 |
12.700 | 300 | 1 |
12.740 | 512 | 1 |
Last trade - 09.48am 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online